2.Gastric Metastasis of Hepatocellular Carcinoma Treated by Transarterial Chemoembolization: A Case Report.
Ji Hoon KIM ; Joong Won PARK ; Joon Il CHOI ; Hyun Beom KIM ; Dong Wook KOH ; Woo Jin LEE ; Chang Min KIM
The Korean Journal of Hepatology 2007;13(1):91-95
Extrahepatic metastasis in patients with hepatocellular carcinoma (HCC) occurs frequently. The most common site of metastasis is the lung, followed by regional lymph nodes and bones. However, gastrointestinal metastasis of HCC is a rare condition and solitary polypoid metastatic lesion on stomach without any evidence of direct invasion from primary mass is very rare. These metastatic lesions are usually asymptomatic, and most are discovered at postmortem examination or are found incidentally during laparotomy. The choice of treatment for gastrointestinal metastatic lesion of HCC includes surgery, transarterial chemoembolization, and local injection but the treatment is often difficult and unsuccessful. We report a case of 69 years old man who presented disappearance of a polypoid metastatic lesion of HCC on the gastric fundus by transarterial chemoembolization.
Aged
;
Carcinoma, Hepatocellular/*diagnosis/secondary/therapy
;
*Chemoembolization, Therapeutic
;
Duodenoscopy
;
Gastric Fundus/radiography
;
Humans
;
Liver Neoplasms/*diagnosis/pathology/therapy
;
Male
;
Stomach Neoplasms/*diagnosis/secondary/therapy
;
Tomography, X-Ray Computed
3.Sigmoid colon metastasis from hepatocellular carcinoma.
Dong Jun YOO ; Young Hwa CHUNG ; Yoon Seon LEE ; Sung Eun KIM ; Young Joo JIN ; Yu Mi LEE ; Mi Jung KIM
The Korean Journal of Hepatology 2010;16(4):397-400
Hepatocellular carcinoma (HCC) is a major health problem worldwide, and it has a poor prognosis. Extrahepatic metastasis from HCC is not unusual, with direct invasion representing the main spreading mode. Sites that are frequently involved are the lung, bone, and lymph nodes. There are few reports of HCC invading the distant gastrointestinal tract, especially hematogenously. Herein we report a case of sigmoid colon metastasis from HCC. The patient was diagnosed with HCC and treated with transcatheter arterial chemoembolization (TACE). Eighteen months after TACE the patient presented with abdominal pain on the left lower quadrant, and a CT scan showed an enhanced mass on the sigmoid colon. Immunohistochemical staining revealed that a tumor cell was positive for polyclonal carcinoembryonic antigen and weakly positive for hepatocyte antigen, supporting the diagnosis of HCC metastasis. The patient underwent anterior resection for the metastatic HCC.
Carcinoembryonic Antigen/metabolism
;
Carcinoma, Hepatocellular/*diagnosis/pathology/*secondary
;
Chemoembolization, Therapeutic
;
Humans
;
Liver Neoplasms/*pathology/therapy
;
Male
;
Middle Aged
;
Sigmoid Neoplasms/*diagnosis/*secondary/ultrasonography
;
Tomography, X-Ray Computed
4.A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016.
Clinical and Molecular Hepatology 2016;22(1):7-17
Many guidelines for hepatocellular carcinoma (HCC) have been published and updated globally. In contrast to other cancers, there is a range of treatment options for HCC involving several multidisciplinary care of the patient. Consequently, enormous heterogeneity in management trends has been observed. To support standard care for HCC, we systematically appraised 8 current guidelines for HCC around the world, including 3 guidelines from Asia, 2 from Europe, and 3 from the United States according to the selection criteria of credibility influence and multi-faceted. After a systematic appraisal, we found that these guidelines have both similarities and dissimilarities in terms of surveillance and treatment allocation recommendations due to regional differences in disease and other variables (diagnosis, staging systems) secondary to the lack of a solid, high level of evidence. In contrast to other tumors, the geographic differences in tumor biology (i.e., areas of increased hepatitis B prevalence) and available resources (organ availability for transplantation, medical technology, accessibility to treatment, health systems, and health resources) make it impractical to have an internationally universal guideline for all patients with HCC. Although Barcelona-Clinic Liver Cancer (BCLC) has long been dominant system for treatment-guiding staging of HCC, many Asia-pacific experts do not fully agree with its principle. The concepts of BCLC, for surgical resection or other locoregional therapy, are considered too conservative. Asian guidelines represent consensus about surgical resection and TACE indication for more advanced tumor.
Algorithms
;
Carcinoma, Hepatocellular/diagnostic imaging/pathology/*therapy
;
Chemoembolization, Therapeutic
;
Guidelines as Topic
;
Humans
;
Liver Neoplasms/diagnosis/pathology/*therapy
;
Liver Transplantation
;
Neoplasm Staging
;
alpha-Fetoproteins/analysis
5.A Case Series of Liver Abscess Formation after Transcatheter Arterial Chemoembolization for Hepatic Tumors.
Wei SUN ; Fei XU ; Xiao LI ; Chen-Rui LI
Chinese Medical Journal 2017;130(11):1314-1319
BACKGROUNDLiver abscess is a serious complication following transcatheter arterial chemoembolization (TACE). Much attention has been paid to this condition as it may interfere with the treatment process and result in a poor prognosis of the patient. This study aimed to analyze the causes of liver abscess, a complication, after TACE for hepatic tumors and to summarize management approaches.
METHODSFrom June 2012 to June 2014, of 1480 consecutive patients who underwent TACE at our hospital, five patients developed liver abscess after TACE procedures for hepatic tumors. Of the five patients, each receiving conventional TACE, one underwent three sessions, two underwent two sessions, and the remaining two underwent one session of TACE. Demographic and clinical characteristics, together with management approaches and prognosis, were collected through a review of medical records.
RESULTSThese five patients were confirmed to have post-TACE liver abscess through clinical manifestations, laboratory, and imaging tests. After percutaneous drainage and anti-inflammatory treatments, the symptoms present in four patients with liver abscess significantly improved as evidenced by shrinkage or disappearance of the abscess cavity, and the patients recovered completely after sufficient drainage. The remaining patient experienced recurrent symptoms and abdominal abscess, achieved no significant improvement after treatment, and eventually died of severe infection and multiple organ failures.
CONCLUSIONSTACE must be implemented with extreme caution to avoid liver abscess. An effective management relies on an early diagnosis, prompt use of sufficient doses of appropriate antibiotics, and active implementation of abscess incision, drainage, and aspiration.
Adult ; Aged ; Carcinoma, Hepatocellular ; therapy ; Chemoembolization, Therapeutic ; adverse effects ; Humans ; Liver ; pathology ; Liver Abscess ; diagnosis ; etiology ; Liver Neoplasms ; therapy ; Male ; Middle Aged ; Retrospective Studies
6.A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy.
Ik YOON ; Hyung Joon YIM ; Jin Nam KIM ; Sun Min PARK ; Jeong Han KIM ; Seung Hwa LEE ; Hwan Hoon CHUNG ; Hong Sik LEE ; Sang Woo LEE ; Jai Hyun CHOI
The Korean Journal of Hepatology 2009;15(1):90-95
Portal vein invasion is a grave prognostic indicator in the setting of hepatocellular carcinoma (HCC). There is currently no effective method for preventing the invasion of HCC into the main portal vein. We report here a case of advanced HCC with portal vein tumor thrombosis that was effectively treated with percutaneous ethanol injection (PEI), having previously enabled subsequent successive transarterial chemoembolization (TACE). A 60-year-old male patient was diagnosed with a huge HCC, based on computed tomography and angiographic findings. Despite two sessions of TACE, the tumor invaded the right portal vein. PEI was performed on the malignant portal vein thrombosis, and three sessions thereof reduced the extent of tumor thrombi in the portal vein. Successive TACEs were performed to treat the HCC in the hepatic parenchyma. The patient was still living 19 months after the first PEI with no evidence of tumor recurrence, and his liver function remained well preserved.
Carcinoma, Hepatocellular/complications/*diagnosis/pathology
;
Chemoembolization, Therapeutic
;
Ethanol/*administration & dosage
;
Humans
;
Injections, Intralesional
;
Liver Neoplasms/complications/*diagnosis/pathology
;
Male
;
Middle Aged
;
Neoplasm Invasiveness
;
*Portal Vein/pathology
;
Tomography, X-Ray Computed
;
Venous Thrombosis/complications/diagnosis/*therapy
7.A Case of Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases.
Jin Hee HONG ; Dong Dae SEO ; Tae Joo JEON ; Tae Hoon OH ; Won Chang SHIN ; Won Choong CHOI ; Hyun Sun CHO
The Korean Journal of Gastroenterology 2010;55(2):133-138
Spontaneous regression of hepatocellular carcinoma (HCC) is extremely rare. We report a case of 67-year-old man having HBV-associated HCC with multiple lung metastases which regressed spontaneously. The patient had single liver mass and received surgical resection. The mass was confirmed as HCC histopathologically. Nine years after surgical resection, a 3.3 cm sized recurred HCC was detected on the resection margin in CT scan. Transarterial chemoembolization (TACE) was performed 3 times, and lung metastases developed thereafter. The patient received 2 more sessions of TACE, however, metastatic lung nodules were in progress very rapidly. We decided to stop TACE and followed the patient regularly without any anti-cancer treatment. Nine months after development of lung metastasis, the size and number of metastatic lung nodules decreased and were not detected anymore after 14 months. Serum alpha-fetoprotein levels also decreased to normal range and no viable tumor was noted in the liver. The patient is still alive 12 years after the first diagnosis of HCC and 16 months after lung metastasis developed.
Aged
;
Carcinoma, Hepatocellular/*pathology/secondary/therapy
;
Chemoembolization, Therapeutic
;
Hepatitis B, Chronic/complications/diagnosis
;
Humans
;
Liver Neoplasms/complications/*pathology/therapy
;
Lung Neoplasms/*diagnosis/radiography/secondary
;
Male
;
Neoplasm Regression, Spontaneous
;
Neoplasm Staging
;
Tomography, X-Ray Computed
;
alpha-Fetoproteins/analysis
8.The clinical characteristic of adrenal metastatic tumor.
Yu-jun LIU ; Guo-min WANG ; Yong-kang ZHANG ; Li ZHANG ; Li-an SUN ; Zong-ming LIN ; Tong-yu ZHU
Chinese Journal of Surgery 2007;45(2):124-127
OBJECTIVETo analyze the clinical features of adrenal metastasis.
METHODSFrom January 1993 to December 2004, 103 cases of adrenal metastasis were reviewed.
RESULTSLung and hepatocellular carcinoma were the most common primary tumor of adrenal metastatic tumor, which about 36.9% (38/103) and 42.7% (44/103) of all cases, followed by renal carcinoma 6.8% (7/103), colorectal carcinoma 4.9% (5/103), stomach carcinoma 3.9% (4/103), breast cancer 1.9% (2/103), unknown primary tumor 2.9% (3/103). Most of these were low differentiation. The mean diameter of adrenal metastasis was 3.9 cm. The mean interval from detection of primary tumor to adrenal metastasis was 9.5 months. And 79.6% (82/103) were detected as a part of multiorgan metastasis. Only 5 cases (4.9%) were presented with pain in the back. There was little characterization of ultrasonography, CT and MRI, color-Doppler and selective arterial imaging showed little blood supply. All of patients were treated with synthetic methods, 16 cases (15.5%) who had undergone adrenalectomy for metastasis disease had a improved survival compared with those non-adrenalectomy.
CONCLUSIONSThere is no particular presentation of clinic and imaging, diagnosis depending on history, follow-up and the pathological presentation of primary tumor. There are no standard treatment guidelines for this group of patients. When the primary tumor could be resected or be well controlled, and there is no other evidence of metastasis, adrenalectomy is recommended. Transarterial chemoembolization (TACE) could not actually be performed.
Adrenal Gland Neoplasms ; diagnosis ; secondary ; therapy ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular ; pathology ; Combined Modality Therapy ; Female ; Humans ; Liver Neoplasms ; pathology ; Lung Neoplasms ; pathology ; Male ; Middle Aged ; Retrospective Studies ; Survival Analysis ; Treatment Outcome
9.Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies.
Jacquelyn W ZIMMERMAN ; Hugo JIMENEZ ; Michael J PENNISON ; Ivan BREZOVICH ; Desiree MORGAN ; Albert MUDRY ; Frederico P COSTA ; Alexandre BARBAULT ; Boris PASCHE
Chinese Journal of Cancer 2013;32(11):573-581
In the past century, there have been many attempts to treat cancer with low levels of electric and magnetic fields. We have developed noninvasive biofeedback examination devices and techniques and discovered that patients with the same tumor type exhibit biofeedback responses to the same, precise frequencies. Intrabuccal administration of 27.12 MHz radiofrequency (RF) electromagnetic fields (EMF), which are amplitude-modulated at tumor-specific frequencies, results in long-term objective responses in patients with cancer and is not associated with any significant adverse effects. Intrabuccal administration allows for therapeutic delivery of very low and safe levels of EMF throughout the body as exemplified by responses observed in the femur, liver, adrenal glands, and lungs. In vitro studies have demonstrated that tumor-specific frequencies identified in patients with various forms of cancer are capable of blocking the growth of tumor cells in a tissue- and tumor-specific fashion. Current experimental evidence suggests that tumor-specific modulation frequencies regulate the expression of genes involved in migration and invasion and disrupt the mitotic spindle. This novel targeted treatment approach is emerging as an appealing therapeutic option for patients with advanced cancer given its excellent tolerability. Dissection of the molecular mechanisms accounting for the anti-cancer effects of tumor-specific modulation frequencies is likely to lead to the discovery of novel pathways in cancer.
Carcinoma, Hepatocellular
;
therapy
;
Cell Proliferation
;
radiation effects
;
Electromagnetic Fields
;
Humans
;
Liver Neoplasms
;
therapy
;
Magnetic Field Therapy
;
adverse effects
;
Neoplasms
;
diagnosis
;
pathology
;
therapy
;
Radiation Dosage
;
Radio Waves
;
Thyroid Neoplasms
;
therapy
;
Treatment Outcome
10.Hemothorax caused by spontaneous rupture of a metastatic mediastinal lymph node in hepatocellular carcinoma: a case report.
Ssang Yong OH ; Kwang Won SEO ; Yangjin JEGAL ; Jong Joon AHN ; Young Joo MIN ; Chang Ryul PARK ; Jae Cheol HWANG
The Korean Journal of Internal Medicine 2013;28(5):622-625
No abstract available.
Carcinoma, Hepatocellular/*complications/*secondary/therapy
;
Embolization, Therapeutic
;
Fatal Outcome
;
Hemothorax/diagnosis/*etiology/therapy
;
Humans
;
Liver Neoplasms/*complications/*pathology/therapy
;
Lymph Nodes/*pathology
;
Lymphatic Metastasis
;
Male
;
Mediastinum
;
Middle Aged
;
Paracentesis
;
Rupture, Spontaneous
;
Tomography, X-Ray Computed
;
Treatment Outcome